Text Box: Preface


Detection, Diagnosis, Evaluation,

& Treatment



PREFACE

 

It is in the neighborhood of 65 years since the most significant advance was made by Drs. Huggins and Hodges who received the Nobel Prize for medicine when they made the discovery that it was the male body’s production of hormones that fed and proliferated prostate cancer (PC).

 

At that time the only method of treatment was an orchiectomy and the female hormone DES.

 

DES was found to cause cardiovascular disease, thrombo embolism, and phlebitis; more patients died from the treatment rather than the disease.  It was abandoned and the methods of treatment – radical prostatectomy, radiation, and later brachytherapy (radioactive seed implants) were given the false title “The Gold Standard of Prostate Cancer Treatment.”

 

In the middle 80’s the diligent research of Dr. Fernand Labrie at Center Hospital University of Laval (CHUL) in Quebec City, Canada, isolated the antiandrogen, Flutamide – a medication taken with an agonist Luteinizing Hormone-Releasing Hormone (LHRH) described as Combination Hormonal Therapy (CHT).

 

With the misleading and fallacious information being fed to the public on prostate cancer, it is no wonder that both the potential cancer patient and the medical profession are in variance with the basics of Detection, Diagnosis, Evaluation and Treatments for the disease.

 

The National Cancer Institute quotes the annual incidence of Prostate Cancer has decreased to 218,890 patients in 2007 with 27,050 deaths.  This is a decrease of 15,570 from 234,460 PC victims diagnosed in 2006.  “This makes prostate cancer the #1 cancer diagnosis for men, accounting for 33 percent of all new cancer diagnoses.”  Many of the newly diagnosed patients could have been diagnosed years ago if the proper detection methods were instituted.  We will never have reliable data until a national registry is mandatory for all forms of cancer with laws enforcing physician compliance within 30 days of detection.

“Let’s Conquer Prostate Cancer In OUR Lifetime”

PAACT Inc. (Patient Advocates for Advanced Cancer Treatments)

PO Box 141695

Grand Rapids, MI  49514

 

1143 Parmelee Ave NW

Grand Rapids, MI  49504

To contact us:

Phone:  616-453-1477

Fax: 616-453-1846

E-mail: paact@paactusa.org